Assignee
MEDIMMUNE LLC
US186 patents
Top patents by PatentIndex Score
US7704497B2Apr 27, 2010
Molecules with extended half-lives, compositions and uses thereof
MEDIMMUNE LLC94 citations99
US7670600B2Mar 2, 2010
Molecules with extended half-lives, compositions and uses thereof
MEDIMMUNE LLC230 citations99
US8012476B2Sep 6, 2011
Molecules with extended half-lives, compositions and uses thereof
MEDIMMUNE LLC55 citations98
US7700735B2Apr 20, 2010
High potency recombinant antibodies and method for producing them
MEDIMMUNE LLC57 citations98
US7658921B2Feb 9, 2010
Molecules with extended half-lives, compositions and uses thereof
MEDIMMUNE LLC185 citations98
US7566458B2Jul 28, 2009
Influenza hemagglutinin and neuraminidase variants
MEDIMMUNE LLC75 citations98
US9574000B2Feb 21, 2017
Anti-human B7-H4 antibodies and their uses
MEDIMMUNE LLC62 citations96
US8475792B2Jul 2, 2013
Molecules with extended half-lives, compositions and uses thereof
MEDIMMUNE LLC49 citations96
US7553489B2Jun 30, 2009
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE LLC44 citations96
US7527800B2May 5, 2009
Influenza hemagglutinin and neuraminidase variants
MEDIMMUNE LLC36 citations96
US8048430B2Nov 1, 2011
Influenza hemagglutinin and neuraminidase variants
MEDIMMUNE LLC37 citations95
US8007793B2Aug 30, 2011
Stabilized liquid anti-RSV antibody formulations
MEDIMMUNE LLC21 citations95
US7785592B2Aug 31, 2010
Stabilized liquid anti-RSV antibody formulations
MEDIMMUNE LLC33 citations95
US7504109B2Mar 17, 2009
Influenza hemagglutinin and neuraminidase variants
MEDIMMUNE LLC34 citations95
US7459162B2Dec 2, 2008
Influenza hemagglutinin and neuraminidase variants
MEDIMMUNE LLC36 citations95
US7670837B2Mar 2, 2010
Non-tumorigenic MDCK cell line for propagating viruses
MEDIMMUNE LLC37 citations94
US7740851B2Jun 22, 2010
Ultra high affinity neutralizing antibodies
MEDIMMUNE LLC35 citations93
US7531342B2May 12, 2009
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
MEDIMMUNE LLC39 citations93
USD878564SMar 17, 2020
Drug delivery implement
MEDIMMUNE LLC36 citations92
USD878563SMar 17, 2020
Drug delivery implement with translucent housing
MEDIMMUNE LLC31 citations92
USD822199SJul 3, 2018
Drug delivery implement
MEDIMMUNE LLC34 citations92
US9988459B2Jun 5, 2018
Anti-IFNAR1 antibodies with reduced Fc ligand affinity
MEDIMMUNE LLC21 citations92
US9527927B2Dec 27, 2016
Modified polypeptides for bispecific antibody scaffolds
MEDIMMUNE LLC41 citations92
US8574593B2Nov 5, 2013
Influenza hemagglutinin and neuraminidase variants
MEDIMMUNE LLC29 citations92
US8354114B2Jan 15, 2013
Multi plasmid system for the production of influenza virus
MEDIMMUNE LLC30 citations92
US8039002B2Oct 18, 2011
Influenza hemagglutinin and neuraminidase variants
MEDIMMUNE LLC16 citations92
US7847082B2Dec 7, 2010
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE LLC26 citations92
US7790655B2Sep 7, 2010
Cell display of antibody libraries
MEDIMMUNE LLC36 citations92
US7744901B2Jun 29, 2010
Influenza hemagglutinin and neuraminidase variants
MEDIMMUNE LLC15 citations92
US7700130B2Apr 20, 2010
Preservation of bioactive materials by spray drying
MEDIMMUNE LLC13 citations92
US7691379B2Apr 6, 2010
Anti-IL-9 antibody formulations
MEDIMMUNE LLC19 citations92
US7659374B2Feb 9, 2010
Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity
MEDIMMUNE LLC28 citations92
US7635568B2Dec 22, 2009
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE LLC39 citations92
US7601356B2Oct 13, 2009
Methods and compositions for increasing replication capacity of an influenza virus
MEDIMMUNE LLC20 citations92
US7585504B2Sep 8, 2009
High affinity antibodies against HMGB1 and methods of use thereof
MEDIMMUNE LLC21 citations92
US7465456B2Dec 16, 2008
Multi plasmid system for the production of influenza virus
MEDIMMUNE LLC18 citations92
US10442854B2Oct 15, 2019
Neutralizing anti-influenza binding molecules and uses thereof
MEDIMMUNE LLC13 citations91
US9879070B2Jan 30, 2018
Antibodies to S. aureus surface determinants
MEDIMMUNE LLC17 citations91
US9845348B2Dec 19, 2017
Methods of treating S. aureus-associated diseases
MEDIMMUNE LLC21 citations91
US9562100B2Feb 7, 2017
Molecules with extended half-lives, compositions and uses thereof
MEDIMMUNE LLC9 citations91
US8795661B2Aug 5, 2014
Molecules with extended half-lives, compositions and uses thereof
MEDIMMUNE LLC16 citations91
US8012736B2Sep 6, 2011
Multi plasmid system for the production of influenza virus
MEDIMMUNE LLC41 citations91
US7829086B2Nov 9, 2010
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
MEDIMMUNE LLC43 citations91
US9738723B2Aug 22, 2017
Humanized anti-OX40 antibodies and uses thereof
MEDIMMUNE LLC20 citations90
US9220775B2Dec 29, 2015
Binding molecules specific for HER3 and uses thereof
MEDIMMUNE LLC15 citations89
US8008443B2Aug 30, 2011
Modulation of antibody effector function by hinge domain engineering
MEDIMMUNE LLC25 citations89
US7582297B2Sep 1, 2009
Methods of treating respiratory conditions
MEDIMMUNE LLC24 citations89
US7700720B2Apr 20, 2010
Antibodies against and methods for producing vaccines for respiratory syncytial virus
MEDIMMUNE LLC25 citations88
US7704720B2Apr 27, 2010
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
MEDIMMUNE LLC26 citations86
US11174304B2Nov 16, 2021
Neutralizing anti-influenza B antibodies and uses thereof
MEDIMMUNE LLC5 citations83
Showing the top 50 of 186 patents by PatentIndex Score.